Global Neuroscience Market Size (2024 - 2029)

The neuroscience market is anticipated to experience growth driven by factors such as the increasing prevalence of brain-associated disorders, advancements in neuroscience and neuro-technology, and heightened research and development expenditures. The COVID-19 pandemic has significantly impacted the market, affecting clinical trials and research workflows, which may slow growth despite a strong product pipeline. Technological innovations and product approvals are also contributing to market expansion. However, challenges such as ethical concerns over animal testing and the high cost of certain instruments may impede market progress.

Market Size of Global Neuroscience Industry

Neuroscience Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 36.60 Billion
Market Size (2029) USD 49.40 Billion
CAGR (2024 - 2029) 6.18 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Low

Major Players

Neuroscience Market Major Players

*Disclaimer: Major Players sorted in no particular order

Neuroscience Market Analysis

The Global Neuroscience Market size is estimated at USD 36.60 billion in 2024, and is expected to reach USD 49.40 billion by 2029, growing at a CAGR of 6.18% during the forecast period (2024-2029).

Factors such as the rising disease burden of brain-associated disorders, advancements in neuroscience and neurotechnology, increasing research and development expenditures, and government funding are the major driving factors for the neuroscience market.

The anticipated rise in the number of patients affected by Alzheimer’s and other dementias underscores the urgent need for innovative treatments and interventions, driving projected growth in the neuroscience market. For instance, according to the Alzheimer’s Association 2024 Alzheimer's Disease Facts and Figures, approximately 6.9 million Americans aged 65 and above were diagnosed with Alzheimer's dementia, with 73% of them being 75 years or older in 2023. As age advances, so does the risk of dementia, leading to a projected rise in the number and proportion of Americans affected by Alzheimer's or other dementias in the coming years.

Similarly, according to the WHO report published in September 2022, more than 55.0 million people lived with dementia globally, and there were nearly 10.0 million new cases every year. Thus, the rising prevalence of neurological disorders among the population is expected to increase the demand for neuroscience technology such as brain imaging and neuro-microscopy, thereby augmenting the market growth during the forecast period.

In addition, technological advancements related to neuroscience for brain-associated disorders are expected to impact the neuroscience market growth positively. For instance, in June 2023, a prominent neuroscientist highlighted that the evolution of advanced neuroimaging techniques is a pivotal advancement in neuroscience in India. Advancements in magnetic resonance imaging (MRI) have been propelled by the evolution of functional MRI (fMRI) techniques and the advent of high-resolution imaging. Thus, such technological advancements increase the efficacy of neuroscience instruments, which is expected to drive market growth over the forecast period.

However, ethical concerns regarding animal experiments and the high cost of specific instruments likely hinder market growth during the forecast period.

Neuroscience Industry Segmentation

As per the scope, neuroscience refers to studying the brain and nervous system, including molecular neuroscience, cognitive neuroscience, psychophysics, computational modeling, and various central and peripheral nervous system disorders.

The neuroscience market is segmented by technology, components, end users, and geography. By technology, the market is segmented into brain imaging, neuro-microscopy, electrophysiology, neuro-cellular manipulation, neuroproteomic analysis, animal behavior analysis, and other technologies. By component, the market is segmented into instruments and consumables and software and services. By end user, the market is segmented into hospitals, diagnostic laboratories, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (USD) for the above segments.

By Technology
Brain Imaging
Neuro-microscopy
Electrophysiology
Neuroproteomic Analysis
Animal Behaviour Analysis
Other Technologies
By Component
Instruments and Consumables
Software and Services
By End User
Hospitals
Diagnostic Laboratories
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Neuroscience Market Size Summary

The neuroscience market is poised for growth, driven by the increasing prevalence of brain-associated disorders and advancements in neurotechnology. The COVID-19 pandemic has underscored the urgency to enhance mental health systems, impacting clinical trials and research workflows, which may slow growth despite a robust product pipeline. Technological innovations, such as FDA-approved brain function monitors and diagnostic imaging equipment, are expected to propel market expansion. The development of effective neurofeedback systems and advancements in brain imaging technologies, particularly MRI, are contributing to the market's positive trajectory. These advancements are supported by significant research and development investments and government funding, which are crucial for addressing the rising disease burden.

North America is anticipated to dominate the neuroscience market, fueled by increased funding for neurodegenerative disease research and the presence of key industry players. The market's competitive landscape includes numerous companies, such as GE Healthcare and Siemens Healthineers, which hold substantial market shares. Product approvals and technological advancements, like portable MRI systems, are key drivers of market growth. The market's expansion is further supported by strategic partnerships and collaborations aimed at enhancing research capabilities and improving patient outcomes. Despite challenges like ethical concerns and high instrument costs, the overall market outlook remains positive, with continued growth expected over the forecast period.

Explore More

Global Neuroscience Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Disease Burden of Brain-associated Disorders

      2. 1.2.2 Advancement in the Field of Neuroscience and Neuro-technology

      3. 1.2.3 Increasing R&D Expenditure and Government Funding

    3. 1.3 Market Restraints

      1. 1.3.1 Ethical Concerns Regarding Animal Experiments

      2. 1.3.2 High Cost of Certain Instruments

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Buyers/Consumers

      2. 1.4.2 Bargaining Power of Suppliers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value – USD)

    1. 2.1 By Technology

      1. 2.1.1 Brain Imaging

      2. 2.1.2 Neuro-microscopy

      3. 2.1.3 Electrophysiology

      4. 2.1.4 Neuroproteomic Analysis

      5. 2.1.5 Animal Behaviour Analysis

      6. 2.1.6 Other Technologies

    2. 2.2 By Component

      1. 2.2.1 Instruments and Consumables

      2. 2.2.2 Software and Services

    3. 2.3 By End User

      1. 2.3.1 Hospitals

      2. 2.3.2 Diagnostic Laboratories

      3. 2.3.3 Other End Users

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Global Neuroscience Market Size FAQs

The Global Neuroscience Market size is expected to reach USD 36.60 billion in 2024 and grow at a CAGR of 6.18% to reach USD 49.40 billion by 2029.

In 2024, the Global Neuroscience Market size is expected to reach USD 36.60 billion.

Neuroscience Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)